Implementation of Home Medication Review in Patients with Chronic Diseases: A Pilot Study in Indonesia

Mega Silviana; Vitarani Dwi Ananda Ningrum; Okti Ratna Mafruhah

doi:10.18502/jpc.v12i4.17452

Mega Silviana Department of Pharmacy, Universitas Islam Indonesia, Yogyakarta, Indonesia
Vitarani Dwi Ananda Ningrum Department of Pharmacy, Universitas Islam Indonesia, Yogyakarta, Indonesia
Okti Ratna Mafruhah Department of Pharmacy, Universitas Islam Indonesia, Yogyakarta, Indonesia

DOI: https://doi.org/10.18502/jpc.v12i4.17452

Keywords: Chronic Diseases; Drug-Related Problems; Home Medication Review; Pharmacist

Abstract

Background: The high prevalence of chronic diseases such as diabetes mellitus, hypertension, and dyslipidemia is a concern for pharmacists. Pharmacists are expected to participate in these efforts by implementing Home Medication Review (HMR). HMR is a community-based collaborative service outside of health facilities that involves physicians and pharmacists to improve the effectiveness of therapy. This study aimed to determine the incidence of drug-related problems (DRPs), the level of patient satisfaction, and the effect of improving the quality of life of patients with chronic diseases who received Home Medication Review services at the Banjarbaru Utara Primary Health Care.

Methods: This study used a quasi-experimental method with a single group pre-test and post-test design. Data were obtained prospectively, from January to May 2024. DRPs were measured by the Pharmaceutical Care Network Europe (PCNE) form. Patient satisfaction was measured using the five-dimensional service quality questionnaire. Quality of life was measured using the EQ-5D-5L questionnaire with the EQ-5D-5L Index and EQ Visual Analog Scale (VAS) parameters.

Results: The study showed that DRPs in patients with chronic diseases before undergoing HMR were 92.50%. Patient satisfaction with HMR services reached 91.33%. Quality of life in chronic disease patients increased, based on the EQ-5D-5L Index, from 0.802 + 0.199 before to 0.854 + 0.189 after HMR (p-value 0.002), and based on the EQ VAS from 72.25 + 12.80 before to 78.12 + 14.19 after HMR (p-value 0.001).

Conclusion: This study concludes that HMR services can identify DRPs, and improve satisfaction, knowledge, and quality of life of patients with chronic disease.